New Key Statistics Module, Z-Score and F-Score
NAS:ALGS Key Ratios
Market Cap $ M | 57.04 |
Enterprise Value $ M | -45.21 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.96 |
Price/Sales | 2.66 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 13.00 |
EPS (TTM) $ | -1.43 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.52 |
EV-to-EBITDA | 0.54 |
PEG | -- |
Shares Outstanding M | 78.11 |
Net Margin (%) | -722.06 |
Operating Margin % | -625.40 |
Pre-tax Margin (%) | -716.41 |
Quick Ratio | 6.25 |
Current Ratio | 6.25 |
ROA % (ttm) | -83.95 |
ROE % (ttm) | -137.90 |
ROIC % (ttm) | -388.41 |
Dividend Yield % | -- |
Altman Z-Score | -6.72 |
ALGS Number of Guru Trades
ALGS Volume of Guru Trades
Gurus Latest Trades with NAS:ALGS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALGS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aligos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ALGS
Total 0- 1